STOCK TITAN

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
OrthoPediatrics Corp. to Release Q4 and Full Year 2023 Financial Results on March 6, 2024
Positive
  • None.
Negative
  • None.

WARSAW, Ind., Feb. 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2023 financial results on Wednesday, March 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Thursday, March 7, 2024, at 8:00 a.m. ET to discuss the results.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 71 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 71 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com 
415-937-5406


OrthoPediatrics Corp. will release its Q4 and full year 2023 financial results on Wednesday, March 6, 2024, after the market closes.

The conference call to discuss the financial results is scheduled for Thursday, March 7, 2024, at 8:00 a.m. ET.

Investors can access the live and archived webcast of the conference call at www.orthopediatrics.com, on the Investors page in the Events & Presentations section.

The webcast will be available for replay for at least 90 days after the event.
OrthoPediatrics corp

NASDAQ:KIDS

KIDS Rankings

KIDS Latest News

KIDS Stock Data

Ophthalmic Goods Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Ophthalmic Goods Manufacturing
US
Warsaw

About KIDS

orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!